Agenda Oncology Update 2024

7 a.m.                          

Registration, Breakfast & View Exhibits

8 a.m.                          

Welcome & Educational Overview

8:10 a.m.                   

Gastrointestinal Malignancies Update

SAN DIEGO - Darren Sigal, MD (Scripps)

IRVINE - Joel Hecht, MD (UCLA)

SEATTLE - Chris Chen, MD (Stanford)

SANTA CLARA - George Fisher, MD (Stanford)

9 a.m.                        

Update in Hematologic Malignancies: Leukemia, Lymphoma and Myeloma

ALL CITIES - Aaron Goodman, MD (UCSD)

9:50 a.m.                   

Break & View Exhibits

10:20 a.m.                 

Genitourinary Cancer Update

SAN DIEGO - Munveer Bhangoo, MD (Scripps)

IRVINE - Munveer Bhangoo, MD (Scripps)

SEATTLE - Petros Grivas, MD (Fred Hutch)

SANTA CLARA - Sandy Srinivas, MD (Stanford)

11:10 a.m.                 

Diagnostic & Therapeutic Advances in Lung Cancer

SAN DIEGO - Aditya Sarvaria, MD (Scripps)

IRVINE - Kamya Sankar, MD (Cedars-Sinai)

SEATTLE - Rafael Santana-Davila, MD (Fred Hutch)

SANTA CLARA - Ronald Natale, MD (Cedars-Sinai)

Noon                           

Lunch       

1 p.m.                          

Updates in Melanoma

SAN DIEGO - Gregory Daniels, MD (UCSD)

IRVINE - Gregory Daniels, MD (UCSD)

SEATTLE - Evan Hall, MD (Fred Hutch)

SANTA CLARA - Alain Algazi, MD (UCSF)

1:50 p.m.                   

Women’s Cancer Update

ALL CITIES - Joanne Mortimer, MD (City of Hope)

2:40 p.m.                   

Adjourn

Topics, times and speakers are subject to change

All symposia are from 7-8 a.m. and 12-1 p.m. in each city. Topics and speakers to be announced.

San Diego:

Breakfast Symposium Hosted by Pfizer

ADCETRIS + AVD Offers the Superior Overall Survival Advantage in a Curative Intent Setting - Raghuveer Ranganathan, MD (USC)

Lunch Symposium Hosted by Lilly

Rethinking BTK Inhibition in Previously Treated CLL/SLL and MCL - Catherine Coombs, MD (UCI School of Medicine) (PDF, 260 KB)

Irvine, Seattle, and Santa Clara:

Breakfast Symposium Hosted by Pfizer

ADCETRIS + AVD Offers the Superior Overall Survival Advantage in a Curative Intent Setting

Irvine - Raghuveer Ranganathan, MD (USC)

Seattle - Raghuveer Ranganathan, MD (USC)

Santa Clara - Mojtaba Akhtari, MD (Loma Linda)

Lunch Symposium Hosted by Pfizer

Review of evidence-based data for an antibody-drug conjugate in combination with a PD-1 inhibitor for 1L la/mUC

Irvine - Sandy Liu, MD (City of Hope)

Seattle - PADCEV, Danko Martincic, MD (Beacon Clinic)

Santa Clara - William Bensinger, MD (Northwest)